NCT05499416 Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis Status WITHDRAWN Phase PHASE4
NCT04314544 Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) Status COMPLETED Phase PHASE3
NCT04314531 Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03881059 Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE2
NCT03357471 Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE3